← Leaderboards
Baodong Sun
Duke University
$3,238,660
Attributed
$3,238,660
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,238,660 · 2
By mechanism
R01$3,238,660 · 2
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Dwight D Koeberl$10,403,079
- Nenad Bursac$22,509,345
- Priya S Kishnani$685,042
- Yuan T Chen$792,683
- Aravind Asokan$26,081,479
Others in their field
Other Rising Stars on “Immune Response”
- Angee Greer · Ppd Development Lp$82,531,927
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Jason Dickens · Duke University$12,259,409
- Suma Babu · Massachusetts General Hospital$11,004,714
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Anice Lowen · Emory University$9,438,846
Research focus
Immune ResponseLiverGenderHumanized MouseInnovationLeadEffective TherapyFoundationsGlycogenHepatotoxicityInfantInheritedClinical TranslationClinical CandidateAdeno-Associated Viral VectorDoseEnzymesFemaleAffectGene TherapyHepatocyteCapsidAdultMediating
Grant awards (5)
Gene therapy for glycogen storage disease type III$643,610
R01 · FY2025 · AR · contact PI
Skeletal muscle-targeted gene therapy for Pompe disease$540,712
R01 · FY2025 · AR · contact PI
Gene therapy for glycogen storage disease type III$646,060
R01 · FY2024 · AR · contact PI
Gene therapy for glycogen storage disease type III$700,802
R01 · FY2023 · AR · contact PI
Gene therapy for glycogen storage disease type III$707,476
R01 · FY2022 · AR · contact PI